COVID-19: China Healthcare Implications for Private Equity Investors Presentations July 14, 2020 Helen Chen Justin Wang Stephen Sunderland
Related Practice Private Equity We are seeking to drive practical insight from China’s experience to inform healthcare investment 01262022160120
Article Life Sciences & Pharma Impact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors July 2, 2024
Article Diagnostics, Tools and Personalized Medicine A New Generation of Drug Therapies Requires New Business Strategies April 29, 2024
Published Articles Marketing & Sales How Can Businesses Survive the ‘Cookie Apocalypse’? April 25, 2024
Article Life Sciences & Pharma The New Map – Shifting geographic priorities for healthcare companies operating in Asia November 1, 2023
Executive Insights Life Sciences & Pharma Initial Drugs Selected for Medicare Price Negotiation: Emerging Perspectives September 1, 2023